Linnea SA, or Linnea, is proud to announce that they are celebrating the company’s 40th anniversary in 2022. Linnea has been manufacturing high quality botanical ingredients at their GMP certified facility in Ticino, Switzerland since 1982.
Linnea produces a suite of natural beneficial botanical ingredients which it supplies to the pharmaceutical, cosmetics and dietary supplement industries, including: Bilberry, Ginkgo Biloba, Red Clover, 5 HTP, HMR Lignan™, Vinpocetine, Vincamine, Butylscopolamine and Cannabinoids.
Since 2016, Linnea has been focusing on producing valuable non-psychoactive cannabinoids. Currently, Linnea Cannabinoids primarily delivers innovative, trustworthy CBD ingredients. CBD is available as a GMP certified full spectrum standardized extract and a 99% pure isolate.
Linnea’s newest product is a standardized full spectrum CBG (Cannabigerol) extract which is available for the food and cosmetics market.
Due to their 40 years of experience, Linnea is proud to have been able to create GMP certified pharmaceutical grade ingredients for companies to use in their product formulations. They believe quality and high standards are vital for cannabis companies and consumers. It is rare to find a company in the cannabinoid industry producing GMP certified pharmaceutical grade products with decades of experience.
Linnea’s mission since its founding has been to improve people’s lives with high-quality standardized products, and they continue to live by this mission today. The company is constantly researching and developing new products and investing in sustainability projects.
For more information about Linnea’s mission or to view their cannabinoid product line, please visit their websites: https://www.linneacannabinoids.ch or www.linnea.ch
